Clinical Trials
250
Active:5
Completed:145
Trial Phases
5 Phases
Phase 1:8
Phase 2:11
Phase 3:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (172 trials with phase data)• Click on a phase to view related trials
Not Applicable
108 (62.8%)Phase 4
39 (22.7%)Phase 2
11 (6.4%)Phase 1
8 (4.7%)Phase 3
6 (3.5%)Trial Examines Short-term Effects of Hippotherapy on Fascia Properties and Quality of Life in Children With CP.
Not Applicable
Not yet recruiting
- Conditions
- Cerebral Palsy (CP)RehabilitationMotor Coordination or FunctionFasciaQuality of LifeHippotherapy
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 27
- Registration Number
- NCT07134582
- Locations
- 🇸🇮
Konjeniški zavod Epona, Novo Mesto, Dolenjska, Slovenia
Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension
- Conditions
- Coarctation of the Aorta
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 50
- Registration Number
- NCT07134621
- Locations
- 🇸🇮
UMC Ljubljana, Ljubljana, Slovenia
Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton
Not Applicable
Not yet recruiting
- Conditions
- Neonatal Adaptation
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 80
- Registration Number
- NCT07109076
- Locations
- 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia
Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit
Not Applicable
Not yet recruiting
- Conditions
- Critical IllnessHyperglycaemiaHypoglycaemia
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 200
- Registration Number
- NCT07088549
- Locations
- 🇸🇮
University Medical Center Ljubljana, Ljubljana, Slovenia
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Not Applicable
Recruiting
- Conditions
- Rehabilitation OutcomeCerebrolysinIschemic Stroke, Acute
- Interventions
- Drug: Cerebrolysin treatmentDrug: The patients in Arm 1 will be treated with cerebrolysin and standard treatment.Other: Standard treatment (including neurorehabilitation) of acute ischemic stroke
- First Posted Date
- 2025-06-29
- Last Posted Date
- 2025-07-09
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 30
- Registration Number
- NCT07043686
- Locations
- 🇸🇮
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), Ljubljana, Slovenia
- Prev
- 1
- 2
- 3
- 4
- 5
- 50
- Next
News
No news found